• The global Non-Invasive Drug Delivery Device market was valued at US$ 1.92 billion in 2023 and is projected to reach US$ 3.14 billion by 2030, at a CAGR of 7.3% during the forecast period. The influence of COVID-19 and the RussiaUkraine War were considered while estimating market sizes.
• Non-Invasive Drug Delivery Device Market aims to provide a comprehensive presentation of the global market for Non-Invasive Drug Delivery Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-Invasive Drug Delivery Device. Non-Invasive Drug Delivery Device Market contains market size and forecasts of Non-Invasive Drug Delivery Device in global, including the following market information:
• Novartis AG • Inovio Pharmaceuticals, Inc. • Medtronic Plc. • Tandem Diabetes Care, Inc. • Teva Pharmaceutical Industries Ltd. • Crossject Medical Technology • Adherium Ltd.
